Cyntellect Awarded $1.3MM Phase II SBIR Grant to Automate Cloning of Cells Based on Protein Secretion
Advertisement
Cyntellect, Inc. announced it will receive approximately $1.3MM in funding under a Phase II Small Business Innovative Research (SBIR) grant for continued new application development on its laser-based LEAP(TM) system.
Specifically, the grant will fund further development of applications using LEAP for automated highspeed purification and cloning of cells based upon their specific secretion of native or recombinant proteins.
"The ability to perform high-speed purification and cloning of cells based on various functional cell properties, such as the secretion rate of specific proteins, opens up exciting new avenues of research activities in areas ranging from biologics discovery to cell line development to cellular diagnostics," stated Dr. Fred Koller, President and CTO. "This grant award recognizes the substantial progress reported from our Phase I efforts and highlights the significance of this LEAP application for contributing to new and important scientific discoveries."